Atlas Venture
Signal active
Investment Firm
Overview
Atlas Venture is an early-stage venture capital firm that creates and invests in biotech startup companies led by promising entrepreneurs focusing on life sciences innovation. Its seed-led venture creation strategy rigorously selects and focuses investment on compelling opportunities to build scalable businesses and realize value.
Highlights
Founded
1980
Industry
Venture Capital
Employees
11-50
Investment
605
Lead Investment
167
Exits
185
Stages
Early Stage Venture, Late Stage Venture, Private Equity, Seed
Investor Type
Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Atlas Venture, established in 1980 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Private Equity, Seed investments across Finance, Retail, Consulting, Financial Services, Venture Capital, Angel Investment, Cyber Security, Business Development, Crowdfunding, Analytics. The organization boasts a portfolio of 602 investments, with an average round size of $31.8M and 185 successful exits. Their recent investments include The Accelerator Group, Index Ventures, Accomplice, Dailymotion, Partech. The highest investment round they participated in was $1364.1B. Among their most notable exits are The Accelerator Group and Index Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Atlas Venture has made 605 investments. Their most recent investment was on Aug 06, 2024, when PHINXT Robotics raised $2.6M.
Atlas Venture has made 69 diversity investments. Their most recent diversity investment was on Mar 25, 2024, when Q32 Bio raised $42.0M.
investments
605
Diversity investments
69
Lead investments
167
Number of exits
185
Investments
605
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jun 14, 2024 | Disc Medicine | Biotechnology | 178.0M |
| Jul 16, 2024 | Scorpion Therapeutics | Biotechnology | 150.0M |
| Jul 19, 2024 | - | - | 60.3M |
| Aug 06, 2024 | PHINXT Robotics | Warehousing | 2.6M |
Exits
185
Funding Timeline
Funding rounds
605
Investors
1
Funds
10
Funding Rounds
605
Atlas Venture has raised 605 rounds. Their latest funding was raised on Aug 06, 2024 from a Seed Round - PHINXT Robotics round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jun 14, 2024 | Post-IPO Equity - Disc Medicine | - | 178.0M | - |
| Jul 16, 2024 | Series C - Scorpion Therapeutics | - | 150.0M | - |
| Jul 19, 2024 | Series B - GRO Biosciences | - | 60.3M | - |
| Aug 06, 2024 | Seed Round - PHINXT Robotics | - | 2.6M | - |
Investors
1
Atlas Venture is funded by 1 investor(s). Renaissance Venture Capital Kantor is the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
Renaissance Venture Capital | Yes | Venture Round - Atlas Venture | 0 |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.